Risk factors for osteoporosis and fracture in patients attending rheumatology outpatient clinics

Australian and New Zealand Journal of Medicine

Volumn 29, Issue 2, 1999, Pages 197-202

  Brand, C A ^a   Jolley, D ^b   Tellus, M ^a   Muirden, K D ^a   Wark, J D ^a  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Osteoporosis; Rheumatology; Risk factors

Indexed keywords

CALCIUM; VITAMIN D;

ADULT; AGED; ARTICLE; BONE ATROPHY; BONE DENSITY; CALCIUM INTAKE; FEMALE; FRACTURE; HIGH RISK PATIENT; HIP FRACTURE; HUMAN; MALE; OSTEOPOROSIS; PREVALENCE; RHEUMATIC DISEASE; RHEUMATOLOGY; RISK FACTOR; VITAMIN BLOOD LEVEL;

EID: 0032922930     PISSN: 00048291     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1445-5994.1999.tb00683.x     Document Type: Article

References (25)

1. 1. Jones G, Nguyen T, Sambrook P et al. Progressive loss of bone at the femoral neck in elderly people: longitudinal findings from the Dubbo osteoporosis epidemiology study. Br Med J 1994; 309: 691-5.
2. 2. Flicker L, Faulkner KG, Hopper JL et al. Determinants of hip axis length in women aged 10-89 years: a twin study. Bone 1996; 18: 41-5.
3. 3. Geusens P. Geometric characteristics of the proximal femur and hip fracture risk. Osteoporosis Int 1996; (Suppl. 3): S27-S30.
4. 4. Melton LJ, Atkinson EJ, O'Fallon WM, Wahner HW, Riggs BL. Long term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res 1993; 8: 1227-33.
5. 5. Cummings SR, Black BM, Nevitt MC et al. Bone density at various sites for prediction of hip fracture. Lancet 1993; 341: 72-5.
6. 6. Purdie DW, Steel SA, Howey S, Doherty SM. The technical and logistical feasibility of population densitometry using DXA and directed HRT intervention: A 2-year prospective study. Osteoporosis Int 1996; (Suppl. 3): S31-S36.
7. 7. Seeman E, Hopper JL, Bach LA et al. Reduced bone mass in daughters of women with osteoporosis. N Engl J Med 1989; 320: 554-8.
8. 8. Cummings SR, Nevitt MC, Browner WS et al. Risk factors for hip fracture in white women. N Engl J Med 1995; 332: 767-73.
9. 9. Dequeker J, Tobing I, Rutten V, Geusens P, MEDOS study group. Relative risk factors for osteoporotic fracture: A pilot study of the MEDOS questionnaire. Clin Rheum 1991; 10: 49-53.
10. 10. Major GAC, Mathers D, Glass J, Ratnarajah S, Weavers H. Anti osteoporosis treatment in rheumatic disease patients - an audit. Aust NZ J Med 1995; 25: 399 (Abstr.).
11. 11. Johnell O, Gullberg B, Kanis JA et al. Risk factors for hip fracture in European women: The MEDOS Study. J Bone Min Res 1995; 10: 1802-15.
12. 12. Earnshaw SA, Hocking DJ. Clinical usefulness of risk factors for osteoporosis (Ed.). Ann Rheum Dis 1996; 55: 338-9.
13. 13. Krall EA, Dawson-Hughes B. Heritable and life-style determinants of bone mineral density. J Bone Min Res 1993; 8: 1-9.
14. 14. Lyritis GP and the MEDOS Study Group. Epidemiology of hip fracture: The MEDOS Study. Osteoporosis Int 1996; (Suppl. 3): S11-15.
15. 15. Riggs BL, Melton LJ III. Involutional osteoporosis. N Engl J Med 1986; 314: 1676-86.
16. 16. Grisso JA, Kelsey JL, Strom BL et al. Risk factors for falls as a cause of hip fracture in women. N Engl J Med 1991; 324: 1326-31.
17. 17. Dawson-Hughes B. Calcium insufficiency and fracture risk. Osteoporosis Int 1996; (Suppl. 3): S37-S41.
18. 18. Michaelsson K, Holmberg L, Ljunghall S, Mallmin H, Persson PG, Wolk A. Effect of prefracture versus post-fracture dietary assessment on hip fracture risk estimates. Intl J Epidem 1996; 25: 403-10.
19. 19. Reid IR, Ames RW, Evans MC, Gamble GD, Sharpe SJ. Longterm effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomised controlled trial. Am J Med 1995; 98: 331-5.
20. 20. Chapuy MC, Arlot ME, Duboeuf F et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992; 327: 1637-42.
21. 21. Lips P, Graafmans WC, Ooms ME, Bezemer PD, Bouter LM. Vitamin D supplementation and fracture incidence in elderly persons. Ann Intern Med 1996; 124: 400-6.
22. 22. Stein MS, Scherer SC, Walton SL et al. Risk factors for secondary hyperparathyroidism in a nursing home population. Clin Endocrinol 1996; 44: 375-83.
23. 23. Tilyard MW, Spears GFS, Thomson J, Dovey S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 1992; 326: 357-62.
24. 24. Sambrook P, Birmingham J, Kelly P et al. Prevention of corticosteroid osteoporosis: A comparison of calcium, calcitriol and calcitonin. N Engl J Med 1993; 328: 1747-52.
25. 25. National Institutes of Health Continuing Medical Education. NIH consensus statement, 1994; Vol. 12, number 4, p. 24.